10 Stocks to Sell According to Jinghua Yan’s TwinBeech Capital
In this article, we discuss 10 stocks to sell according to Jinghua Yan's TwinBeech Capital.
Posts Tagged ‘NYSE:EBS’
Should Consider Disposing Your Emergent BioSolutions (EBS) Shares?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” second quarter 2021 investor letter – a copy of which can be...
Should You Be Tempted To ‘Sell’ Emergent Biosolutions (EBS) Stock?
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here.
Here’s Why Emergent BioSolutions (EBS) Became One of Carillon’s Worst Securities
Carillon Tower Advisers, an investment management firm, published its fourth quarter 2020 “Carillon Eagle Small Cap Growth Fund” investor letter – a copy of which can be...
Is Emergent Biosolutions (EBS) Stock a Buy For 2021?
Baron Discovery Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Is EBS A Good Stock To Buy Now According To Hedge Funds?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Is Emergent BioSolutions (EBS) a Smart Long-term Buy?
Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Hedge Funds Are Piling Into Emergent Biosolutions Inc (EBS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Emergent Biosolutions Inc (EBS) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Are Betting On Emergent Biosolutions Inc (EBS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%.
Should You Avoid Emergent Biosolutions Inc (EBS)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Hedge Funds Have Never Been This Bullish On Emergent Biosolutions Inc (EBS)
Is Emergent Biosolutions Inc (NYSE:EBS) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Here’s What Hedge Funds Think About Emergent Biosolutions Inc (EBS)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Here’s What Hedge Funds Think About Emergent Biosolutions Inc (EBS)
Is Emergent Biosolutions Inc (NYSE:EBS) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment...
Is Emergent Biosolutions Inc (EBS) A Good Stock To Buy ?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics ...
Hedge Funds Are Buying Emergent Biosolutions Inc (EBS)
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Dumping Emergent Biosolutions Inc (EBS)
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Ophthotech Corp (OPHT), First Solar, Inc. (FSLR), and More: Analysts Had This to Say About Some of The Week’s Top Movers
Although the broader markets barely moved for the last week of the third quarter with the S&P 500 up around 0.14% and the Dow Jones 0.26% in green, shares of five companies, ...
Here’s Why These Five Stocks Are on the Move Today
All three major indexes are in the green as Deutsche Bank AG (USA) (NYSE:DB) worries fade.
Two Under The Radar Biotech Decisions To Watch Next Month
August is going to be a big month in biotech, with a number of drugs up for FDA review.
Here’s Why These Five Stocks Are on the Move Today
In a marked reversal, crude futures are off 1.4% today after a disappointing EIA report, while the broader indexes are each higher as traders await the 'Brexit' outcome tomorrow...
Here’s Why United Continental, Cirrus Logic, Viacom and Two Other Stocks are Moving Today
Among the stocks on investors' radars today are United Continental Holdings Inc (NYSE:UAL), Reynolds American, Inc. (NYSE:RAI), Viacom, Inc.
Emergent Biosolutions Inc (EBS): How Hedge Funds Are Trading This Biotech Stock
Insider Monkey recently finished processing more than 700 13F filings made by hedge funds and prominent investors.
Investing in Counteracting Biological and Chemical Agents
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological...
Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)
Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal the latest moves made by...
Spectrum Pharmaceuticals, Inc. (SPPI): Are Hedge Funds Right About This Stock?
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
Do Hedge Funds and Insiders Love Sequenom, Inc. (SQNM)?
If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times.
QLT Inc. (USA) (QLTI): Are Hedge Funds Right About This Stock?
In the financial world, there are many indicators shareholders can use to analyze Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Hedge Funds Are Selling Emergent Biosolutions Inc (EBS)
To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age.
ChemoCentryx Inc (CCXI): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
ChemoCentryx Inc (NASDAQ:CCXI) was in 6 hedge funds' portfolio at the end of March. CCXI has experienced an increase in enthusiasm from smart money recently.
Should You Buy Protalix BioTherapeutics Inc. (PLX)?
At the moment, there are many indicators shareholders can use to watch the equity markets. Two of the most innovative are hedge fund and insider trading activity.
Sangamo Biosciences, Inc. (SGMO): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
In the 21st century investor’s toolkit, there are a multitude of metrics market participants can use to track stocks.
Is Spectrum Pharmaceuticals, Inc. (SPPI) Going to Burn These Hedge Funds?
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was in 12 hedge funds' portfolio at the end of the first quarter of 2013.
Here is What Hedge Funds Think About Sequenom, Inc. (SQNM)
To most traders, hedge funds are seen as worthless, outdated investment tools of the past.
Emergent Biosolutions Inc (EBS): Hedge Funds and Insiders Are Bearish, What Should You Do?
Emergent Biosolutions Inc (NYSE:EBS) was in 15 hedge funds' portfolio at the end of the first quarter of 2013.
Should You Avoid Idenix Pharmaceuticals Inc (IDIX)?
Is Idenix Pharmaceuticals Inc (NASDAQ:IDIX) an excellent stock to buy now? Investors who are in the know are taking a bearish view.
Do Hedge Funds and Insiders Love QLT Inc. (USA) (QLTI)?
In today’s marketplace, there are tons of metrics shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading sentiment.
Is Emergent Biosolutions Inc (NYSE:EBS) Going to Burn These Hedge Funds?
Emergent Biosolutions Inc (NYSE:EBS) was in 17 hedge funds' portfolio at the end of the fourth quarter of 2012.
Has Avanir Pharmaceuticals, Inc. (AVNR) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
